Approval · Notice of Compliance 2697 · 1998
ACYCLOVIR: Notice of Compliance 2697
Issued March 4, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2697
- Date
- March 4, 1998
- Company
- Faulding (Canada) Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Antiviral agent
- Canadian reference product
- ZOVIRAX (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACYCLOVIR | 02236916 | Cancelled Post Market |
Medicinal ingredients
- ACYCLOVIR 25 MG per ML